Fight Aging! Newsletter Explores Breakthroughs in Age-Related Disease Therapies and Longevity Research
April 6, 2025
The Fight Aging! newsletter, distributed to thousands of subscribers, focuses on modern medicine's potential to end age-related diseases.
It includes news and articles on various topics related to aging and longevity, such as metabolic syndrome, macrophages, and innovative therapies.
The newsletter also discusses studies on the gut microbiome, cardiovascular health, and neurodegeneration, highlighting the interconnectedness of these factors in aging.
Recent research emphasizes the increased mortality risk associated with metabolic syndrome and sarcopenia, with data indicating higher all-cause mortality rates in affected individuals.
Research indicates a correlation between the severity of sarcopenia, characterized by muscle loss, and arterial stiffness or hypertension, suggesting a relationship between these age-related conditions.
In Alzheimer's patients, a more inflammatory B cell population has been identified, contributing to the chronic inflammation associated with the disease.
The concept of 'bioenergetic age' suggests that an individual's ability to maintain energy metabolism may predict Alzheimer's disease risk, with higher acylcarnitine levels indicating greater cognitive decline.
The Klotho gene, linked to longevity and health, has therapeutic potential for age-related diseases as its increased expression can improve cognitive function and protect against kidney damage.
Targeting senescent cells has shown promise in treating age-related conditions, with senolytic therapies selectively eliminating these dysfunctional cells.
Excess visceral fat tissue is associated with increased inflammation and metabolic diseases, particularly in postmenopausal women, highlighting the importance of healthy body fat distribution.
SPP1+ macrophages are linked to chronic inflammation and age-related diseases, indicating a need for new therapeutic approaches to manage inflammation and tissue dysfunction.
Recent research on gene therapy of VEGF-C shows promise in restoring cerebrospinal fluid drainage in aged mice, potentially improving brain function and reducing inflammation.
Summary based on 2 sources
Get a daily email with more Science stories
Sources

Fight Aging! • Mar 22, 2025
Fight Aging! Newsletter, March 24th 2025
Fight Aging! • Apr 5, 2025
Fight Aging! Newsletter, April 7th 2025